The global Equine Healthcare market gathered revenue around USD 1.2 Billion in 2020 and market is set to grow USD 2.5 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.2% during the prediction period 2021 to 2027.
Growth Factors:
The global equine healthcare market is rising due to horse racing trend, global development programs for animal health, and increasing incidence of equine infections. Presence of various companies in the manufacturing of variety products in the market will boost the consumption of the equine healthcare products. The competition among the companies have led the companies to expand geographically thus, boosting the market. These market strategies will likely promote growth opportunities during the forecast period.
The trend of horse racing in various countries across the globe even after several government regulations is fueling the market. Large number of horse owners showing interest in attending equine racings, shows, and events are increasing the demand for expensive quality breed of horses that provide high returns by exporting them to locations such as China can highly fuel the market.
A significant growth in awareness regarding the common diseases impacting overall equines performance is observed across major parts of the globe over the period of past few years. This factor has helped in the diagnosis and prevention of many diseases in equines, and thereby bringing sizable demand opportunities for companies engaged in the global market for equine healthcare. Vaccines, drugs, and supplemental feed additives are some of the product types available in the market for equines healthcare.
Although the market is expected to face certain restrains due to decreasing number of equine species worldwide, the rise in demand for insurance of pet will potentially open new scope for global equine healthcare market in the coming years.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Equine Healthcare market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Equine Healthcare market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 2.5 Billion by 2027 |
Growth Rate | CAR 5.6.2% From 2021 to 2027 |
Base Year | 2021 |
Forecast Period | 2021 to 2027 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Segments Covered | Product Type, Disease, Distribution Channel and Region |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Companies Mentioned | Ceva Santé Animale, Equine Products (UK) Ltd., Sanofi, Eli Lilly and Company, and Vetoquinol S.A.. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Equine Healthcare market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America and Europe: Lucrative Regions Fueling Market Growth
In terms of region, the global equine healthcare market shows presence in many geographical regions including Latin America, Asia Pacific, North America, the Middle East and Africa, and Europe. Of them, North America and Europe are considered leading market growth regions. According to the market analysis of equine healthcare, these regions are expected to show promising growth opportunities during the forecast period of 2021 to 2027.There are several factors that many boost market growth, such as growing equines adoption rate per household, growth in expenditure towards equine care activities, and sturdy business operations of many well-entrenched companies in the region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Equine Healthcare Market include: Ceva Santé Animale, Equine Products (UK) Ltd., Sanofi, Eli Lilly and Company, and Vetoquinol S.A.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product Type
By Disease
By Distribution Channel
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Equine Healthcare market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Equine Healthcare market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Equine Healthcare markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Equine Healthcare market Study: